Cargando…

Patterns of Bisphosphonates Utilization in Patients under Age 45 in a Large Cohort of Commercial Insurance Beneficiaries in the United States

BACKGROUND: The effectiveness and safety of bisphosphonates treatment used in the young population have not been well studied. Despite insufficient data on effectiveness and safety of bisphosphonates in young patients, bisphosphonates are still considered in younger patients at high risk for osteopo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Jing, Tong, Angela, Kim, Seoyoung C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303413/ https://www.ncbi.nlm.nih.gov/pubmed/25611596 http://dx.doi.org/10.1371/journal.pone.0115091

Ejemplares similares

Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US
por: Sandhaus, Robert, et al.
Publicado: (2020)

Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United States
por: Elsaid, Mohamed I., et al.
Publicado: (2020)

Dose patterns in commercially insured subjects chronically exposed to opioids: a large cohort study in the United States
por: Cepeda, Maria Soledad, et al.
Publicado: (2010)

Utilization patterns and characteristics of users of biologic anti‐inflammatory agents in a large, US commercially insured population
por: Mendelsohn, Aaron B., et al.
Publicado: (2020)

Utilization Patterns and Outcomes of People With Diabetes and COVID-19: Evidence From United States Medicare Beneficiaries in 2020
por: Austin, Andrea M., et al.
Publicado: (2022)

663. Characteristics, Treatment Patterns, and Outcomes of Outpatients With Rickettsial Diseases in a Large, Commercially Insured Population: United States, 2005–2016
por: Binder, Alison, et al.
Publicado: (2018)

PO-05-187 DOES COVID-19 INCREASE THE RISK OF ATRIAL FIBRILLATION? A RETROSPECTIVE ANALYSIS OF A LARGE ADMINISTRATIVE CLAIMS DATABASE OF COMMERCIALLY INSURED NON-ELDERLY AND MEDICARE ADVANTAGE BENEFICIARIES IN THE UNITED STATES.
por: Berman, Adam E., et al.
Publicado: (2023)

Treatment Patterns and Antipsychotic Medication Adherence Among Commercially Insured Patients With Schizoaffective Disorder in the United States
por: Joshi, Kruti, et al.
Publicado: (2016)

Effect of Insurance on Prescription Drug Use by ESRD Beneficiaries
por: Shih, Ya-chen Tina
Publicado: (1999)

Sporotrichosis Cases in Commercial Insurance Data, United States, 2012–2018
por: Benedict, Kaitlin, et al.
Publicado: (2020)

Postpartum care visits among commercially insured women in the United States
por: Butwick, Alexander J., et al.
Publicado: (2022)

Economic Burden of HIV in a Commercially Insured Population in the United States
por: Chen, Cindy Y., et al.
Publicado: (2023)

Epidemiology of rhegmatogenous retinal detachment in commercially insured myopes in the United States
por: Ludwig, Cassie A., et al.
Publicado: (2023)

Duration in and Pattern of Utilization Under Children's Health Insurance Programs
por: Lin, Chyongchiou J., et al.
Publicado: (1998)

Prevalence, treatment patterns, and healthcare resource utilization in Medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the United States
por: St. Peter, Wendy L., et al.
Publicado: (2018)

DataView: Trends and Current Drug Utilization Patterns of Medicaid Beneficiaries
por: Lied, Terry R., et al.
Publicado: (2006)

Causes of Death among Commercially Insured Multiple Sclerosis Patients in the United States
por: Goodin, Douglas S., et al.
Publicado: (2014)

Presumed ocular histoplasmosis syndrome in a commercially insured population, United States
por: Benedict, Kaitlin, et al.
Publicado: (2020)

Opioid and benzodiazepine dispensing and co-dispensing patterns among commercially insured pregnant women in the United States, 2007–2015
por: Qato, Danya M., et al.
Publicado: (2021)

Trends in life expectancy among medical aid beneficiaries and National Health Insurance beneficiaries in Korea between 2004 and 2017
por: Bahk, Jinwook, et al.
Publicado: (2019)

Over-the-Counter Medicine Utilization by Beneficiaries Under Medical Schemes in South Africa
por: Padayachee, N, et al.
Publicado: (2020)

MCBS Highlights: Supplemental Insurance for Community Aged and Disabled Beneficiaries: 1999
por: Murray, Lauren A., et al.
Publicado: (2002)

Utilization and Costs of Compounded Medications for Commercially Insured Patients, 2012-2013
por: McPherson, Timothy, et al.
Publicado: (2016)

Real-world treatment modalities, health care resource utilization, and costs among commercially insured patients with newly diagnosed major depressive disorder in the United States
por: Pizzicato, Lia N, et al.
Publicado: (2023)

Coccidioidomycosis Skin Testing in a Commercially Insured Population, United States, 2014–2017
por: Benedict, Kaitlin, et al.
Publicado: (2020)

Direct and Indirect Costs of Infectious Conjunctivitis in a Commercially Insured Population in the United States
por: Pepose, Jay S, et al.
Publicado: (2020)

Cannabis Use and Fungal Infections in a Commercially Insured Population, United States, 2016
por: Benedict, Kaitlin, et al.
Publicado: (2020)

Health Care Costs of Anal Cancer in a Commercially Insured Population in the United States
por: Wu, Chi-Fang, et al.
Publicado: (2018)

1428. Lyme Disease Treatment in the United States: Prescribing Patterns from a Nationwide Commercial Insurance Database, 2016-2018
por: Beeson, Amy M, et al.
Publicado: (2020)

Patient characteristics, treatment patterns, and outcomes of Rickettsial diseases among a commercially insured population in the United States, 2005–2017
por: Binder, Alison M., et al.
Publicado: (2021)

Medicaid Highlights: 2003 Medicaid Versus Commercial Beneficiary Experience with Care
por: Lied, Terry R.
Publicado: (2005)

Healthcare costs and utilization for Medicare beneficiaries with Alzheimer's
por: Zhao, Yang, et al.
Publicado: (2008)

The impact of high-risk and chronic opioid use among commercially insured endometriosis patients on health care resource utilization and costs in the United States
por: Estes, Stephanie J, et al.
Publicado: (2020)

Healthcare Resource Utilization and Costs Among Commercially Insured Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States
por: Kobayashi, Monica, et al.
Publicado: (2023)

Direct Contributions by the Organization to the Health Insurance Cost of Beneficiaries of the CERN Pension Fund
Publicado: (1995)

Direct Contributions by the Organization to the Health Insurance Cost of Beneficiaries of the CERN Pension Fund
Publicado: (1995)

Potentially Avoidable Hospitalization among Long-Term Care Insurance Beneficiaries with Dementia
por: Kim, Jae-Hyun, et al.
Publicado: (2020)

Utilization and Costs of Gender-Affirming Care in a Commercially Insured Transgender Population
por: Baker, Kellan, et al.
Publicado: (2022)

Utilization and Spending on Mental Health Services Among Children and Youths With Commercial Insurance
por: Kalmin, Mariah M., et al.
Publicado: (2023)

Patterns of 6-mercaptopurine and azathioprine maintenance therapy among a cohort of commercially insured individuals diagnosed with Crohn’s disease in the United States
por: Lund, Jennifer L, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_cg628c5a5bltuc5tjp9dmgrk6b